• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克服三阴性乳腺癌治疗中植物化学物质的挑战:前进之路。

Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward.

作者信息

Alaouna Mohammed, Penny Clement, Hull Rodney, Molefi Thulo, Chauke-Malinga Nkhensani, Khanyile Richard, Makgoka Malose, Bida Meshack, Dlamini Zodwa

机构信息

SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Cancer Research Institute (PACRI), University of Pretoria, Pretoria 0001, South Africa.

Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Parktown 2193, South Africa.

出版信息

Plants (Basel). 2023 Jun 16;12(12):2350. doi: 10.3390/plants12122350.

DOI:10.3390/plants12122350
PMID:37375975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10301029/
Abstract

Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptor expression. TNBC is thought to be produced by Wnt, Notch, TGF-beta, and VEGF pathway activation, which leads to cell invasion and metastasis. To address this, the use of phytochemicals as a therapeutic option for TNBC has been researched. Plants contain natural compounds known as phytochemicals. Curcumin, resveratrol, and EGCG are phytochemicals that have been found to inhibit the pathways that cause TNBC, but their limited bioavailability and lack of clinical evidence for their use as single therapies pose challenges to the use of these phytochemical therapies. More research is required to better understand the role of phytochemicals in TNBC therapy, or to advance the development of more effective delivery mechanisms for these phytochemicals to the site where they are required. This review will discuss the promise shown by phytochemicals as a treatment option for TNBC.

摘要

三阴性乳腺癌(TNBC)是一种侵袭性很强的乳腺癌亚型,缺乏雌激素、孕激素和HER2受体表达。TNBC被认为是由Wnt、Notch、TGF-β和VEGF通路激活产生的,这会导致细胞侵袭和转移。为了解决这个问题,人们对使用植物化学物质作为TNBC的治疗选择进行了研究。植物含有被称为植物化学物质的天然化合物。姜黄素、白藜芦醇和表没食子儿茶素没食子酸酯(EGCG)是已被发现能抑制导致TNBC的通路的植物化学物质,但它们有限的生物利用度以及缺乏作为单一疗法使用的临床证据,给这些植物化学物质疗法的应用带来了挑战。需要更多的研究来更好地理解植物化学物质在TNBC治疗中的作用,或者推进开发更有效的将这些植物化学物质输送到所需部位的机制。本综述将讨论植物化学物质作为TNBC治疗选择所展现出的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/9cd569356780/plants-12-02350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/11cd36b67c80/plants-12-02350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/6821f0e9c677/plants-12-02350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/64762a022776/plants-12-02350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/e9c84a35f6f7/plants-12-02350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/9cd569356780/plants-12-02350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/11cd36b67c80/plants-12-02350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/6821f0e9c677/plants-12-02350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/64762a022776/plants-12-02350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/e9c84a35f6f7/plants-12-02350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a5/10301029/9cd569356780/plants-12-02350-g005.jpg

相似文献

1
Overcoming the Challenges of Phytochemicals in Triple Negative Breast Cancer Therapy: The Path Forward.克服三阴性乳腺癌治疗中植物化学物质的挑战:前进之路。
Plants (Basel). 2023 Jun 16;12(12):2350. doi: 10.3390/plants12122350.
2
Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells.Wnt信号通路阻断抑制三阴性乳腺癌细胞的增殖和迁移,并诱导其凋亡。
J Transl Med. 2013 Nov 4;11:280. doi: 10.1186/1479-5876-11-280.
3
Breast Tumor Microenvironment: Emerging target of therapeutic phytochemicals.乳腺肿瘤微环境:治疗性植物化学物质的新兴靶点。
Phytomedicine. 2020 Apr 16;70:153227. doi: 10.1016/j.phymed.2020.153227.
4
Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer.姜黄素:激素非依赖性乳腺癌关键分子信号通路的调节剂
Cancers (Basel). 2021 Jul 8;13(14):3427. doi: 10.3390/cancers13143427.
5
Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.低剂量紫杉醇联合 XAV939 通过抑制 Wnt 信号通路抑制乳腺癌转移、血管生成和生长。
Cells. 2019 Aug 14;8(8):892. doi: 10.3390/cells8080892.
6
Targeting Triple-Negative Breast Cancer by the Phytopolyphenol Carnosol: ROS-Dependent Mechanisms.植物多酚鼠尾草酸靶向三阴性乳腺癌:依赖活性氧的机制
Antioxidants (Basel). 2023 Jun 27;12(7):1349. doi: 10.3390/antiox12071349.
7
Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype.基于三阴乳腺癌内在亚型的潜在治疗靶点
Oncotarget. 2017 Aug 16;8(42):73329-73344. doi: 10.18632/oncotarget.20274. eCollection 2017 Sep 22.
8
Sesamol inhibits proliferation, migration and invasion of triple negative breast cancer via inactivating Wnt/β-catenin signaling.芝麻酚通过抑制 Wnt/β-连环蛋白信号通路抑制三阴性乳腺癌的增殖、迁移和侵袭。
Biochem Pharmacol. 2022 Dec;206:115299. doi: 10.1016/j.bcp.2022.115299. Epub 2022 Oct 13.
9
The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer.天然产物在治疗三阴性乳腺癌中的潜力。
Curr Cancer Drug Targets. 2022;22(5):388-403. doi: 10.2174/1568009622666211231140623.
10
miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.miR-221/222 通过激活 Wnt/β-catenin 信号通路促进三阴性乳腺癌的发生。
J Mol Cell Biol. 2018 Aug 1;10(4):302-315. doi: 10.1093/jmcb/mjy041.

引用本文的文献

1
Targeting Triple-Negative Breast Cancer: Resistance Mechanisms and Therapeutic Advancements.靶向三阴性乳腺癌:耐药机制与治疗进展
Cancer Med. 2025 May;14(9):e70803. doi: 10.1002/cam4.70803.
2
Synthesis, Structure, and Stability of Copper(II) Complexes Containing Imidazoline-Phthalazine Ligands with Potential Anticancer Activity.含咪唑啉-酞嗪配体且具有潜在抗癌活性的铜(II)配合物的合成、结构与稳定性
Pharmaceuticals (Basel). 2025 Mar 6;18(3):375. doi: 10.3390/ph18030375.
3
Leveraging Cholesterol-Functionalized Cyclodextrin Nanosponges for Enhanced Drug Delivery in Cancer Cells.

本文引用的文献

1
Capsaicin and cancer: Guilty as charged or innocent until proven guilty?辣椒素与癌症:罪名成立还是无罪推定?
Temperature (Austin). 2022 Jan 11;10(1):35-49. doi: 10.1080/23328940.2021.2017735. eCollection 2023.
2
Current and future burden of breast cancer: Global statistics for 2020 and 2040.乳腺癌的现状和未来负担:2020 年和 2040 年全球统计数据。
Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.
3
Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer.
利用胆固醇功能化环糊精纳米海绵增强癌细胞中的药物递送
Int J Mol Sci. 2025 Jan 30;26(3):1213. doi: 10.3390/ijms26031213.
4
Harnessing the nutriceutics in early-stage breast cancer: mechanisms, combinational therapy, and drug delivery.早期乳腺癌的营养治疗学:机制、联合治疗和药物传递。
J Nanobiotechnology. 2024 Sep 18;22(1):574. doi: 10.1186/s12951-024-02815-8.
5
Fractionation and phytochemical composition of an ethanolic extract of leaves: antioxidant and anticancerous properties in human triple negative breast cancer cells.树叶乙醇提取物的分级分离及植物化学成分:对人三阴性乳腺癌细胞的抗氧化和抗癌特性
Front Pharmacol. 2024 Feb 9;15:1331843. doi: 10.3389/fphar.2024.1331843. eCollection 2024.
肿瘤微环境中脂肪因子表达的改变促进三阴性乳腺癌的发展。
Cancers (Basel). 2022 Aug 26;14(17):4139. doi: 10.3390/cancers14174139.
4
Brassinin Promotes the Degradation of Tie2 and FGFR1 in Endothelial Cells and Inhibits Triple-Negative Breast Cancer Angiogenesis.油菜素内酯促进内皮细胞中Tie2和FGFR1的降解并抑制三阴性乳腺癌血管生成。
Cancers (Basel). 2022 Jul 21;14(14):3540. doi: 10.3390/cancers14143540.
5
Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer.PI3K/AKT/mTOR 和 MAPK/MEK/ERK 抑制的免疫调节特性增强了黑色素瘤和三阴性乳腺癌对免疫检查点阻断的反应。
Int J Mol Sci. 2022 Jul 1;23(13):7353. doi: 10.3390/ijms23137353.
6
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer.三阴性乳腺癌免疫治疗的进展与展望
Front Oncol. 2022 Jun 20;12:919072. doi: 10.3389/fonc.2022.919072. eCollection 2022.
7
Computational and In Vitro Approaches to Elucidate the Anti-cancer Effects of Arnica montana in Hormone-Dependent Breast Cancer.计算与体外方法阐明山金车在激素依赖性乳腺癌中的抗癌作用。
Homeopathy. 2022 Nov;111(4):288-300. doi: 10.1055/s-0042-1743565. Epub 2022 Jul 5.
8
Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells.关于合成二吲哚基甲烷衍生物对三阴性乳腺癌细胞作用方式的研究。
Basic Clin Pharmacol Toxicol. 2022 Oct;131(4):224-240. doi: 10.1111/bcpt.13767. Epub 2022 Jul 8.
9
Targeting Signaling Pathway by Curcumin in Osteosarcoma.姜黄素靶向治疗骨肉瘤的信号通路。
Curr Mol Pharmacol. 2023;16(1):71-82. doi: 10.2174/1874467215666220408104341.
10
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response.抗CTLA-4和抗PD-1免疫疗法在具有独立调节性T细胞反应的临床前乳腺癌和结肠癌模型中可抑制肿瘤进展。
Transl Oncol. 2022 Jun;20:101405. doi: 10.1016/j.tranon.2022.101405. Epub 2022 Mar 24.